UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

207 Perceptions of the Vaccinated and Unvaccinated to Inform Translation to Health and Public Health Practice

Journal of clinical and translational science, 2023-04, Vol.7 (s1), p.64-64

2023

Volltextzugriff (PDF)

Response to ‘Rituximab in membranous nephropathy’

Kidney international, 2008-08, Vol.74 (3), p.392-392

2008

Volltextzugriff (PDF)

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22090-e22090

2020

Volltextzugriff (PDF)

A phase II study of biomarker-driven early discontinuation of anti–PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.TPS9591-TPS9591

2022

Volltextzugriff (PDF)

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e22078-e22078

2020

Volltextzugriff (PDF)

The impact of weight loss on physical function in overweight or obese breast cancer survivors

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.12053-12053

2020

Volltextzugriff (PDF)

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis

Journal of clinical oncology, 2020-02, Vol.38 (5_suppl), p.60-60

2020

Volltextzugriff (PDF)

Biomarker testing in non-small cell lung cancer (NSCLC): An assessment of current practices in precision oncology in the community setting—A trial of the ECOG-ACRIN cancer research group (EAQ161CD)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.e18649-e18649

2021

Volltextzugriff (PDF)

United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.9504-9504

2019

Volltextzugriff (PDF)

Kommunikationsentwicklung und Konfliktklarung

Gestalt review, 2005-01, Vol.9 (2), p.227-227

Cohen, Irvin

2005

Volltextzugriff (PDF)

Home blood pressure monitoring

American family physician, 1996-08, Vol.54 (2), p.537

1996

Volltextzugriff (PDF)

A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and vulvovaginal melanomas: A trial of the ECOG-ACRIN Cancer Research Group (E2607)

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9501-9501

2016

Volltextzugriff (PDF)

The Veterans Administration Medical Care Program

The New England journal of medicine, 1963-11, Vol.269 (19), p.1011-1014

Cohen, Irvin J.

1963

Volltextzugriff (PDF)

Gestalt Therapy and Psychoanalysis: Toward a Better Understanding of a Figure-Ground Relationship

Gestalt review, 1998-01, Vol.2 (3), p.232-252

1998

Volltextzugriff (PDF)

Concurrent Use of Insight and Desensitization Therapy

Psychiatry (Washington, D.C.), 1980-05, Vol.43 (2), p.146-154

1980

Volltextzugriff (PDF)

Report of the Speaker

The American journal of psychiatry, 1988-10, Vol.145 (10), p.1342-1344

COHEN, IRVIN M.

1988

Volltextzugriff (PDF)

Why Should Dialysis Benefit Schizophrenia?

The journal of nervous and mental disease, 1979-08, Vol.167 (8), p.475-477

1979

Volltextzugriff (PDF)

COMPLICATIONS OF CHLORPROMAZINE THERAPY

The American journal of psychiatry, 1956-08, Vol.113 (2), p.115-121

COHEN, IRVIN M

1956

Volltextzugriff (PDF)

Report of the Speaker-Elect

The American journal of psychiatry, 1987-10, Vol.144 (10), p.1397-1397

COHEN, IRVIN M.

1987

Volltextzugriff (PDF)

Addition of Time-Limited Psychotherapy to Medical Treatment in a General Medical Clinic: Results at One-Year Follow-up

The journal of nervous and mental disease, 1981-12, Vol.169 (12), p.780-790

1981

Volltextzugriff (PDF)

Coccidioidomycosis in renal replacement therapy

Archives of internal medicine (1960), 1982-03, Vol.142 (3), p.489

1982

Volltextzugriff (PDF)

Liver function and hepatic complications in patients receiving chlorpromazine

Journal of the American Medical Association, 1955-09, Vol.159 (2), p.99

1955

Volltextzugriff (PDF)

Glucagon receptor gene mutations with hyperglucagonemiabut without the glucagonoma syndrome

世界胃肠外科杂志：英文版（电子版）, 2015 (4), p.60-66

Helen C Miller Mark Kidd Irvin M Modlin Patrizia Cohen Roberto Dina Panagiotis Drymousis Panagiotis Vlavianos Günter Kl？ppel Andrea Frilling

2015

Volltextzugriff (PDF)

Alopecia areata

Archives of general psychiatry, 1967-11, Vol.17 (5), p.608

1967

Volltextzugriff (PDF)

Cutaneous sensitivity reactions to chlorpromazine

Journal of the American Medical Association, 1956-11, Vol.162 (10), p.946

1956

Volltextzugriff (PDF)

1 – 25 von 115

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(104)
Mit Volltextzugriff
(91)

Publikationsform

Sprache

Englisch
(115)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

207 Perceptions of the Vaccinated and Unvaccinated to Inform Translation to Health and Public Health Practice

Response to ‘Rituximab in membranous nephropathy’

Unknown primary tumor high-risk melanoma as a unique patient population with distinct prognosis in the adjuvant setting: An ECOG-ACRIN E1609 study analysis

A phase II study of biomarker-driven early discontinuation of anti–PD-1 therapy in patients with advanced melanoma (PET-Stop): ECOG-ACRIN EA6192

Patient-reported outcomes among patients with resected high-risk melanoma (AJCC7 IIIB, IIIC, M1a, M1b) randomized to low- or high-dose adjuvant Ipilimumab (ipi) versus high-dose interferon alfa-2b (HDI): Health-related quality of life (HRQL) analysis of ECOG-ACRIN E1609

The impact of weight loss on physical function in overweight or obese breast cancer survivors

Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of hormone replacement and immunosuppressants, and association with outcome: E1609 study analysis

Biomarker testing in non-small cell lung cancer (NSCLC): An assessment of current practices in precision oncology in the community setting—A trial of the ECOG-ACRIN cancer research group (EAQ161CD)

United States Intergroup E1609: A phase III randomized study of adjuvant ipilimumab (3 or 10 mg/kg) versus high-dose interferon-α2b for resected high-risk melanoma

Kommunikationsentwicklung und Konfliktklarung

Home blood pressure monitoring

A phase II trial of dasatinib in patients with unresectable locally advanced or stage IV mucosal, acral, and vulvovaginal melanomas: A trial of the ECOG-ACRIN Cancer Research Group (E2607)

The Veterans Administration Medical Care Program

Gestalt Therapy and Psychoanalysis: Toward a Better Understanding of a Figure-Ground Relationship

Concurrent Use of Insight and Desensitization Therapy

Report of the Speaker

Why Should Dialysis Benefit Schizophrenia?

COMPLICATIONS OF CHLORPROMAZINE THERAPY

Report of the Speaker-Elect

Addition of Time-Limited Psychotherapy to Medical Treatment in a General Medical Clinic: Results at One-Year Follow-up

Coccidioidomycosis in renal replacement therapy

Liver function and hepatic complications in patients receiving chlorpromazine

Glucagon receptor gene mutations with hyperglucagonemiabut without the glucagonoma syndrome

Alopecia areata

Cutaneous sensitivity reactions to chlorpromazine

Suchergebnisse filtern